Novo Nordisk’s Ozempic Could Be Key to Lowering Alzheimer’s Risk, According to New Research Medicine & Technology 02:51 AM A recent study suggests that Novo Nordisk's diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease by 40% to 70% in patients with Type 2 diabetes.
How New Technology Supports People with Dyslexia, ADHD, and Autism: Ayoa — A Productivity Tool That Suits Neurodiverse Users